|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
68kD (hsp-70) antibodies
Test Code18406
CPT Codes
84181<br>Restricted Client Code
Preferred Specimen
2 mL serum
Minimum Volume
1 mL
Instructions
Centrifuge and aliquot serum/plasma into plastic vial.
Transport Temperature
Frozen
Specimen Stability
Room temperature: 72 hours
Refrigerated: 5 days
Frozen: 1 year
Refrigerated: 5 days
Frozen: 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly hemolyzed • Lipemic samples
Methodology
Western Blot
Setup Schedule
Set up: Once per week; Report available: 7 days
Reference Range
See Laboratory Report
Clinical Significance
Sensorineural hearing loss (SNHL), commonly referred to as nerve deafness, maybe caused by genetic factors, acquired factors (i.e. infections) or can be immune mediated. In the majority of cases, no cause of SNHL is apparent. Such cases are referred to as idiopathic SNHL. A subgroup of idiopathic SNHL cases is treatable with immunosuppressive therapy. The laboratory studies used to identify these cases should include serum antibody tests to 68kD (hsp-70) inner ear antigen. 22% of patients with bilateral rapidly progressive SNHL have antibodies that react with the 68kD antigen. 68kD (hsp-70 antibodies also occur in approximately 60% of patients with bilateral Meniere's disease, 35% of patients with unilateral Meniere's disease and 37% of patients with contralateral delayed endolymphatic hydrops. In situations where corticosteroids are contraindicated, methotrexate or cytoxan treatment may be prescribed.

